Contains fulltext : 69254.pdf (publisher's version ) (Closed access)The most important factor for tumour recurrence after breast-saving surgery is the margin status. In the Netherlands a 1-mm free margin has been formulated as sufficient, and totally free margins are not necessary in all cases. The current Dutch Health Inspectorate performance indicator, i.e. 10% reexcisions allowed to achieve free margins, is a performance indicator of questionable validity. As long as there is worldwide discussion about the ideal margin in breast-saving surgery a specific norm cannot not be dictated. The aim of the discussion should be how to prevent local recurrence. This percentage is the real performance indicator
Purpose In contrast to other countries, the Dutch breast cancer guideline does not recommend re-exci...
Background Invasive lobular breast carcinoma is known for its multicentricity and is associated with...
Background: In recent years there has been a growing awareness of the quality of breast cancer care....
The most important factor for tumour recurrence after breast-saving surgery is the margin status. In...
Contains fulltext : 49640.pdf (publisher's version ) (Closed access)There is incre...
To examine the incidence of residual disease in re-excisional surgical specimens after breast conser...
There is increasing evidence that local recurrence after breast-conserving surgery may lead to an in...
textabstractPurpose: In contrast to other countries, the Dutch breast cancer guideline does not reco...
Purpose All Dutch hospitals are obliged to report their 5-year ipsilateral breast tumor recurrence (...
Purpose All Dutch hospitals are obliged to report their 5-year ipsilateral breast tumor recurrence (...
Purpose: All Dutch hospitals are obliged to report their 5-year ipsilateral breast tumor recurrence ...
Purpose: All Dutch hospitals are obliged to report their 5-year ipsilateral breast tumor recurrence ...
Purpose In contrast to other countries, the Dutch breast cancer guideline does not recommend re-exci...
Background Invasive lobular breast carcinoma is known for its multicentricity and is associated with...
Purpose In contrast to other countries, the Dutch breast cancer guideline does not recommend re-exci...
Purpose In contrast to other countries, the Dutch breast cancer guideline does not recommend re-exci...
Background Invasive lobular breast carcinoma is known for its multicentricity and is associated with...
Background: In recent years there has been a growing awareness of the quality of breast cancer care....
The most important factor for tumour recurrence after breast-saving surgery is the margin status. In...
Contains fulltext : 49640.pdf (publisher's version ) (Closed access)There is incre...
To examine the incidence of residual disease in re-excisional surgical specimens after breast conser...
There is increasing evidence that local recurrence after breast-conserving surgery may lead to an in...
textabstractPurpose: In contrast to other countries, the Dutch breast cancer guideline does not reco...
Purpose All Dutch hospitals are obliged to report their 5-year ipsilateral breast tumor recurrence (...
Purpose All Dutch hospitals are obliged to report their 5-year ipsilateral breast tumor recurrence (...
Purpose: All Dutch hospitals are obliged to report their 5-year ipsilateral breast tumor recurrence ...
Purpose: All Dutch hospitals are obliged to report their 5-year ipsilateral breast tumor recurrence ...
Purpose In contrast to other countries, the Dutch breast cancer guideline does not recommend re-exci...
Background Invasive lobular breast carcinoma is known for its multicentricity and is associated with...
Purpose In contrast to other countries, the Dutch breast cancer guideline does not recommend re-exci...
Purpose In contrast to other countries, the Dutch breast cancer guideline does not recommend re-exci...
Background Invasive lobular breast carcinoma is known for its multicentricity and is associated with...
Background: In recent years there has been a growing awareness of the quality of breast cancer care....